These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16533713)

  • 21. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization.
    Hartenfeller M; Proschak E; Schüller A; Schneider G
    Chem Biol Drug Des; 2008 Jul; 72(1):16-26. PubMed ID: 18564216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A scalable approach to combinatorial library design for drug discovery.
    Sharma P; Salapaka S; Beck C
    J Chem Inf Model; 2008 Jan; 48(1):27-41. PubMed ID: 18052333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced HTS hit selection via a local hit rate analysis.
    Posner BA; Xi H; Mills JE
    J Chem Inf Model; 2009 Oct; 49(10):2202-10. PubMed ID: 19795815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voyages to the (un)known: adaptive design of bioactive compounds.
    Schneider G; Hartenfeller M; Reutlinger M; Tanrikulu Y; Proschak E; Schneider P
    Trends Biotechnol; 2009 Jan; 27(1):18-26. PubMed ID: 19004513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of combinatorial libraries for the exploration of virtual hits from fragment space searches with LoFT.
    Lessel U; Wellenzohn B; Fischer JR; Rarey M
    J Chem Inf Model; 2012 Feb; 52(2):373-9. PubMed ID: 22148673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment.
    Mayer SC; Banker AL; Boschelli F; Di L; Johnson M; Kenny CH; Krishnamurthy G; Kutterer K; Moy F; Petusky S; Ravi M; Tkach D; Tsou HR; Xu W
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3641-5. PubMed ID: 18501599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity-oriented synthesis; a spectrum of approaches and results.
    Spandl RJ; Bender A; Spring DR
    Org Biomol Chem; 2008 Apr; 6(7):1149-58. PubMed ID: 18362950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid molecules with a dual mode of action: dream or reality?
    Meunier B
    Acc Chem Res; 2008 Jan; 41(1):69-77. PubMed ID: 17665872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping algorithms for molecular similarity analysis and ligand-based virtual screening: design of DynaMAD and comparison with MAD and DMC.
    Eckert H; Vogt I; Bajorath J
    J Chem Inf Model; 2006; 46(4):1623-34. PubMed ID: 16859294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A practical method for targeted library design balancing lead-like properties with diversity.
    Stocks MJ; Wilden GR; Pairaudeau G; Perry MW; Steele J; Stonehouse JP
    ChemMedChem; 2009 May; 4(5):800-8. PubMed ID: 19360802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Descriptor-free molecular discovery in large libraries by adaptive substituent reordering.
    McAllister SR; Feng XJ; DiMaggio PA; Floudas CA; Rabinowitz JD; Rabitz H
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5967-70. PubMed ID: 18851908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A similarity-based data-fusion approach to the visual characterization and comparison of compound databases.
    Medina-Franco JL; Maggiora GM; Giulianotti MA; Pinilla C; Houghten RA
    Chem Biol Drug Des; 2007 Nov; 70(5):393-412. PubMed ID: 17927720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V; Nováková O
    Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.
    San Juan AA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1181-94. PubMed ID: 18155520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategy for discovering chemical inhibitors of human cyclophilin a: focused library design, virtual screening, chemical synthesis and bioassay.
    Li J; Zhang J; Chen J; Luo X; Zhu W; Shen J; Liu H; Shen X; Jiang H
    J Comb Chem; 2006; 8(3):326-37. PubMed ID: 16677001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural product-like chemical space: search for chemical dissectors of macromolecular interactions.
    Reayi A; Arya P
    Curr Opin Chem Biol; 2005 Jun; 9(3):240-7. PubMed ID: 15939325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring biologically relevant chemical space with metal complexes.
    Meggers E
    Curr Opin Chem Biol; 2007 Jun; 11(3):287-92. PubMed ID: 17548234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential synergism and inhibitors to multiple target enzymes of Xuefu Zhuyu Decoction in cardiac disease therapeutics: a computational approach.
    Huang Q; Qiao X; Xu X
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1779-83. PubMed ID: 17236764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.